肾性贫血的负担

The burden of renal anemia

贫血是慢性肾脏病(chronic kidney disease,CKD)的主要并发症,给广大CKD患者带来巨大的健康、生活及经济负担,同时也给社会带来沉重的经济负担。当前肾性贫血的达标率还不理想。在临床中需要准确评估肾性贫血治疗的靶目标,合理有效地应用纠正贫血药物,开发经济、有效的新型抗贫血药物。肾性贫血的治疗对于减轻CKD患者及社会的负担,提高患者生活质量,改善临床预后有着重要的意义。

Anemia is a common complication among chronic kidney disease patients, which affects health and quality of life of the patients, and imposes a tremendous economic burden for patients and society.Currently, the compliance rate of renal anemia is unsatisfactory. Accurate evaluation of the target of renal anemia treatment, rational and effective use of anti-anemia drugs, and development of economical and effective new anti-anemia drugs are essential in clinical practice. Treatment of renal anemia can be of great significance to reduce the burden of patients and society, improve the quality of life in CKD patients, delay the disease progression, and improve the clinical prognosis.